Thus, we conclude that aberrant loss of SIK2 may contribute to hyper-activation of Ras/ERK and PI3K/Akt signaling pathways, thereby, takes part in tumor development via perturbing the delicate balance between proliferation and survival of breast cells. The gene discussed is AKT1; the disease is neoplasm.